CYTO - Why Altamira Therapeutics (CYTO) Stock Is Down 50% Today | Benzinga
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading lower by 50% to $0.20 Monday morning after the company recently made strategic moves by partially spinning off its Bentrio business to focus on RNA delivery.
The company also said a 20-for-1 reverse stock split is set for December 13. This move aims to attract institutional investors and meet Nasdaq's standards before 2023 ends.
What Happened?
This transition involved selling a 51% ...
CYTO) Stock Is Down 50% Today>Full story available on Benzinga.com